Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
6.92
-0.07 (-1.00%)
At close: Sep 28, 2026, 4:00 PM EDT
6.92
0.00 (0.00%)
After-hours: Sep 28, 2026, 7:30 PM EDT
Lifeward Revenue
Lifeward had revenue of $6.62M in the quarter ending June 30, 2026, with 15.71% growth. This brings the company's revenue in the last twelve months to $21.82M, down -10.68% year-over-year. In the year 2025, Lifeward had annual revenue of $22.03M, down -14.14%.
Revenue (ttm)
$21.82M
Revenue Growth
-10.68%
P/S Ratio
0.90
Revenue / Employee
$269,407
Employees
81
Market Cap
19.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.03M | -3.63M | -14.14% |
| Dec 31, 2024 | 25.66M | 11.81M | 85.24% |
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | 4.87M | -1.67M | -25.55% |
| Dec 31, 2018 | 6.55M | -1.21M | -15.58% |
| Dec 31, 2017 | 7.75M | 1.88M | 32.10% |
| Dec 31, 2016 | 5.87M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| Nortech Systems | 124.65M |
| Cytosorbents | 37.22M |
| Baird Medical Investment Holdings | 24.49M |
| Pulsenmore | 14.13M |
| NeuroOne Medical Technologies | 12.47M |
| InspireMD | 10.84M |
| Sintx Technologies | 1.33M |
LFWD News
- 3 days ago - Lifeward Proxy statement: Proxy filing - Filings
- 13 days ago - Peer-Reviewed Study of Lifeward's ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain - GlobeNewsWire
- 13 days ago - Lifeward Proxy statement: Proxy filing - Filings
- 20 days ago - Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy - GlobeNewsWire
- 20 days ago - Lifeward Slides: Investor presentation - Filings
- 4 weeks ago - Lifeward CEO Mark Grant to depart, Josh Hexter named interim CEO - TheFly
- 4 weeks ago - Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer - GlobeNewsWire
- 6 weeks ago - Lifeward Earnings release: Q2 2026 - Filings